EMPAGLIFLOZIN (Jardiance®)
Clinical Indication
Chronic heart failure with preserved or mildly reduced fraction and reduced ejection fraction
Comments
In line with NICE TA929 and NICE TA773
Date of classification
May 2022
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .